Genital Diseases: Clinical Trials

28,996 trials for Genital Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15874 completed, 4188 unknown, 3200 recruiting, 2024 terminated. 8872 Not applicable, 6167 Phase 2, 4231 Phase 1, 2912 Phase 3, 1710 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8872Completed 4669, Unknown 1453, Recruiting 1135, Not yet recruiting 454, Active not recruiting 419, Terminated 412, Withdrawn 225, Enrolling by invitation 75, Suspended 30
Phase 26167Completed 3280, Terminated 745, Recruiting 675, Unknown 620, Active not recruiting 340, Withdrawn 258, Not yet recruiting 219, Suspended 23, Enrolling by invitation 7
Phase 14231Completed 2510, Terminated 472, Recruiting 441, Unknown 316, Active not recruiting 216, Withdrawn 156, Not yet recruiting 88, Suspended 22, Enrolling by invitation 10
Phase 32912Completed 1773, Unknown 331, Recruiting 241, Terminated 221, Active not recruiting 174, Withdrawn 85, Not yet recruiting 74, Suspended 10, Enrolling by invitation 3
Phase 41710Completed 1046, Unknown 305, Terminated 139, Recruiting 76, Withdrawn 52, Not yet recruiting 47, Active not recruiting 31, Enrolling by invitation 8, Suspended 6
Early Phase 1341Completed 144, Unknown 65, Recruiting 35, Terminated 29, Active not recruiting 26, Withdrawn 23, Not yet recruiting 15, Enrolling by invitation 3, Suspended 1

Follow Genital Diseases: new trials by email Literature Review of Genital Diseases trials Research Report on Genital Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria
(a) Training and (b) Supported risk assessment - Prostate Cancer, Risk Assessment
Not applicableNot yet recruitingAhmadu Bello University892029-03-012026-07-29
Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization
smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS)
Not applicableNot yet recruitingKeck School of Medicine of USC2502028-09-012025-10-22
Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors
Exercise and dietary recommendations - Ovarian Cancer
Not applicableNot yet recruitingOncare Madrid322028-05-012026-10-08
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended phase 2 regime - Cancer, Prostate Cancer
Phase 1 / Phase 2Not yet recruitingCHU de Quebec-Universite Laval5002028-03-012025-03-30
Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders
Ginger, Placebo - Women With Coagulation Disorders
Early Phase 1Not yet recruitingUniversity of Valladolid742028-02-012026-05-19
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV
Brief Videos for HIV Stigma - HIV, Mental Health
Not applicableNot yet recruitingCity University of New York, School of Public Health39002028-01-012026-10-01
Perioperative Esketamine Safety and Efficacy in Reducing Postoperative ENDometriosis PAIN (the ENDPAIN Trial): a Randomized Controlled Trial.
Esketamine, Placebo - Endometriosis
Phase 4Not yet recruitingRegion Skane10002028-01-012026-10-19
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
SD-ART - Hiv
Not applicableNot yet recruitingYale University1392027-10-012026-08-31
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines
Not applicableNot yet recruitingUniversity of Florida12962027-09-152026-09-14
Fertility Impact of Microplastics - Advancing Countermeasures and Tracking
Infertility, Microplastics Exposure
Not yet recruitingUniversity of Kragujevac10002027-09-012026-05-01
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants
REGN21353, Nezastomig, Sarilumab Prophylaxis (Contingency) - Metastatic Castration-Resistant Prostate Cancer, mCRPC
Phase 1 / Phase 2Not yet recruitingRegeneron Pharmaceuticals1922027-06-282026-09-30
Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida
Workforce Development (WD) strategies, Quality Management (QM) and Mystery Shopper (MS) Feedback - Hiv
Not applicableNot yet recruitingFlorida State University812027-06-012026-10-13
Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity
Povidone-iodine 5% solution - Cesarean Section, Surgical Site Infection
Not applicableNot yet recruitingMohamed Mousa Mohamed Mousa6002027-05-012026-07-20
Advanced HIV Re-engagement in Care
ARC - Advanced HIV Disease
Not applicableNot yet recruitingUniversity of Alabama at Birmingham7242027-05-012026-07-23
Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)
DOSE-CC Intervention: Educational Sessions - Cervical Cancer Screening, Cervical Cancer
Not applicableNot yet recruitingBoston Medical Center800002027-05-012025-11-10
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection
WithdrawnAIDS Malignancy Consortium2027-04-302025-06-06

Showing 20 of 28996. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (6443)  ·  HIV Infections (4674)  ·  Ovarian Neoplasms (3258)  ·  Acquired Immunodeficiency Syndrome (3029)  ·  Uterine Cervical Neoplasms (2241)  ·  Infertility (1985)  ·  Endometrial Neoplasms (1387)  ·  Breast Neoplasms (1186)  ·  Neoplasms (959)  ·  Polycystic Ovary Syndrome (949)  ·  Endometriosis (885)  ·  Fallopian Tube Neoplasms (827)  ·  Prostatic Hyperplasia (805)  ·  Carcinoma, Ovarian Epithelial (784)  ·  Erectile Dysfunction (667)

Broader conditions

Urogenital Diseases (28976)  ·  Neoplasms (13794)  ·  Neoplasms by Site (13133)  ·  Urogenital Neoplasms (12917)  ·  Female Urogenital Diseases and Pregnancy Complications (11912)  ·  Female Urogenital Diseases (11802)  ·  Genital Diseases, Female (11026)  ·  Male Urogenital Diseases (9744)  ·  Genital Diseases, Male (9172)  ·  Infections (8232)  ·  Communicable Diseases (7847)  ·  Virus Diseases (7513)  ·  Sexually Transmitted Diseases, Viral (7352)  ·  Sexually Transmitted Diseases (7351)

Interventions

Paclitaxel (579)  ·  Carboplatin (565)  ·  Docetaxel (388)  ·  Cisplatin (361)  ·  Zidovudine (318)  ·  Ritonavir (312)  ·  Radiotherapy (293)  ·  Bevacizumab (279)  ·  Prednisone (275)  ·  pembrolizumab (267)  ·  Lamivudine (260)  ·  Magnetic Resonance Spectroscopy (252)  ·  Metformin (246)  ·  Surveys and Questionnaires (246)  ·  Leuprolide (229)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1093)  ·  National Cancer Institute (NCI) (548)  ·  M.D. Anderson Cancer Center (309)  ·  Memorial Sloan Kettering Cancer Center (255)  ·  ViiV Healthcare (248)  ·  University of California, San Francisco (246)  ·  GlaxoSmithKline (240)  ·  Merck Sharp & Dohme LLC (203)  ·  University of Washington (187)  ·  Bayer (167)  ·  University Health Network, Toronto (162)  ·  Assiut University (149)  ·  Gynecologic Oncology Group (146)  ·  AstraZeneca (145)  ·  Mayo Clinic (141)

Countries

United States (12215)  ·  China (2106)  ·  France (1823)  ·  Canada (1819)  ·  Italy (1392)  ·  Spain (1368)  ·  United Kingdom (1328)  ·  Germany (1006)  ·  Belgium (848)  ·  Egypt (762)  ·  Netherlands (722)  ·  Turkey (Türkiye) (708)  ·  Australia (707)  ·  South Korea (685)  ·  Brazil (586)

Top investigators

Lei Li, M.D. (40)

Results publications

PMID 37185961, PMID 41276263, PMID 37407274, PMID 32779730, PMID 34350976, PMID 35170751, PMID 39324693, PMID 40190112, PMID 32898291, PMID 25820067, PMID 33539543, PMID 24722180, PMID 33270906, PMID 33538338, PMID 41698328, PMID 21059176, PMID 34878624, PMID 35506389, PMID 25974235, PMID 27008889, PMID 27422279, PMID 33465252, PMID 36165742, PMID 36884035, PMID 36971688, PMID 37462232, PMID 38421243, PMID 38421252, PMID 39695768, PMID 40966692, PMID 19238149, PMID 19935017, PMID 22894553, PMID 24119319, PMID 24326304, PMID 25712310, PMID 25819287, PMID 26972555, PMID 27626136, PMID 29272162, PMID 29476499, PMID 30633128, PMID 32184277, PMID 32994091, PMID 33901188, PMID 34817414, PMID 34843602, PMID 34895272, PMID 36396498, PMID 37070660

NIH funding

2023 (122), U10CA027469 (95), 2017 (77), 2025 (77), U10CA180868 (74), 2019 (69), 2016 (67), 2018 (67), 2008 (66), 2014 (58), 2009 (56), 2015 (50), P30CA033572 (42), P30CA016672 (35), 2005 (30)